Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine

BACKGROUND: The SARS-CoV-2 pandemic has led to the development of the first mRNA vaccines used in humans. The vaccines are well tolerated, safe, and highly efficacious; however, post-marketing surveillance is revealing potential rare adverse effects. We report a case of symptomatic acute myocarditis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tailor, Prashant D, Feighery, Aoife M, El-Sabawi, Bassim, Prasad, Abhiram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422333/
https://www.ncbi.nlm.nih.gov/pubmed/34514306
http://dx.doi.org/10.1093/ehjcr/ytab319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422333/
https://www.ncbi.nlm.nih.gov/pubmed/34514306
http://dx.doi.org/10.1093/ehjcr/ytab319

Ejemplares similares